Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leandro Blas

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Anticancer Research|July 20, 2021
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Masaki Shiota, Shigetomo Yamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 8, 2022
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomyKen Lee, Masaki Shiota, Dai Takamatsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN StudyLeandro Blas, Masaki Shiota, Takuma Kato, et al.
European Journal of Immunology|April 6, 2024
Tumor-associated macrophages impair NK cell IFN-γ production and contribute to tumor progression in clear cell renal cell carcinomaSol Yanel Núñez, Aldana Trotta, María Victoria Regge, et al.
Oncoimmunology|August 8, 2022
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncologyFlorencia Secchiari, Sol Yanel Nuñez, Jessica Mariel Sierra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC studyLeandro Blas, Masaki Shiota, Hideaki Miyake, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
World Journal of Urology|March 3, 2025
Primary management of prostate cancer by universal health coverage effective coverage indexLeandro Blas, Masaki Shiota, Mizuki Onozawa, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Anticancer Research|July 20, 2021
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Masaki Shiota, Shigetomo Yamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 8, 2022
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomyKen Lee, Masaki Shiota, Dai Takamatsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN StudyLeandro Blas, Masaki Shiota, Takuma Kato, et al.
European Journal of Immunology|April 6, 2024
Tumor-associated macrophages impair NK cell IFN-γ production and contribute to tumor progression in clear cell renal cell carcinomaSol Yanel Núñez, Aldana Trotta, María Victoria Regge, et al.
Oncoimmunology|August 8, 2022
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncologyFlorencia Secchiari, Sol Yanel Nuñez, Jessica Mariel Sierra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC studyLeandro Blas, Masaki Shiota, Hideaki Miyake, et al.
JCO Clinical Cancer Informatics|April 25, 2025
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC StudyMasaki Shiota, Shota Nemoto, Ryo Ikegami, et al.
World Journal of Urology|March 3, 2025
Primary management of prostate cancer by universal health coverage effective coverage indexLeandro Blas, Masaki Shiota, Mizuki Onozawa, et al.
Pageof 8